VE

VELTRA Corporation

Global OTA for curated tours & experiences, focusing on travel to and from Japan.

7048 | T

Overview

Corporate Details

ISIN(s):
JP3835830005
LEI:
Country:
Japan
Address:
中央区日本橋2−13−12
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

VELTRA Corporation is a global online travel agency (OTA) specializing in the booking of tours, activities, and unique local experiences. Since 2004, the company has connected travelers with a vast, curated selection of options, ranging from sightseeing excursions and cultural workshops to admission tickets for attractions. VELTRA's business comprises an OTA platform and a tourism IT segment, serving a global customer base with a strategic focus on both inbound tourism to Japan and outbound travel for the Japanese market. Emphasizing quality and richness, VELTRA aims to provide "genuine experiences" that create lasting memories, distinguishing itself through expert curation and a diverse portfolio of activities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:33
Regulatory News Service
確認書
Japanese 8.0 KB
2025-08-14 08:32
Interim Report
半期報告書-第36期(2025/01/01-2025/12/31)
Japanese 177.0 KB
2025-03-27 08:49
Post-Annual General Meeting Information
臨時報告書
Japanese 26.9 KB
2025-03-27 08:48
Registration Form
確認書
Japanese 8.0 KB
2025-03-27 08:48
Governance Information
内部統制報告書-第35期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-27 08:47
Annual Report
有価証券報告書-第35期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2025-03-04 09:00
Regulatory News Service
確認書
Japanese 8.1 KB
2025-03-04 09:00
Regulatory News Service
確認書
Japanese 8.1 KB
2025-03-04 08:56
Regulatory News Service
訂正有価証券報告書-第33期(2022/01/01-2022/12/31)
Japanese 503.5 KB
2025-03-04 08:56
Regulatory News Service
訂正有価証券報告書-第34期(2023/01/01-2023/12/31)
Japanese 724.0 KB
2024-08-14 09:41
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-08-14 09:40
Interim Report
半期報告書-第35期(2024/01/01-2024/12/31)
Japanese 162.3 KB
2024-05-14 09:35
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-05-14 09:34
Quarterly Report
四半期報告書-第35期第1四半期(2024/01/01-2024/03/31)
Japanese 136.3 KB
2024-03-28 08:50
Post-Annual General Meeting Information
臨時報告書
Japanese 21.4 KB

Automate Your Workflow. Get a real-time feed of all VELTRA Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for VELTRA Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for VELTRA Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.